135 related articles for article (PubMed ID: 35396178)
1. Obesity in Cystic fibrosis: prevalence, trends and associated factors data from the US cystic fibrosis foundation patient registry.
Szentpetery S; Fernandez GS; Schechter MS; Jain R; Flume PA; Fink AK
J Cyst Fibros; 2022 Sep; 21(5):777-783. PubMed ID: 35396178
[TBL] [Abstract][Full Text] [Related]
2. Overweight and obesity in patients with cystic fibrosis: a center-based analysis.
Hanna RM; Weiner DJ
Pediatr Pulmonol; 2015 Jan; 50(1):35-41. PubMed ID: 24757043
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: a population-based cohort study.
Stephenson AL; Mannik LA; Walsh S; Brotherwood M; Robert R; Darling PB; Nisenbaum R; Moerman J; Stanojevic S
Am J Clin Nutr; 2013 Apr; 97(4):872-7. PubMed ID: 23388659
[TBL] [Abstract][Full Text] [Related]
4. The Changing Landscape of Nutrition in Cystic Fibrosis: The Emergence of Overweight and Obesity.
Bailey J; Krick S; Fontaine KR
Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334873
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and factors associated with overweight and obesity in adults with cystic fibrosis: A single-center analysis.
Harindhanavudhi T; Wang Q; Dunitz J; Moran A; Moheet A
J Cyst Fibros; 2020 Jan; 19(1):139-145. PubMed ID: 31727452
[TBL] [Abstract][Full Text] [Related]
6. [Italian Cystic Fibrosis Registry (ICFR). Report 2015-2016].
Giordani B; Amato A; Majo F; Ferrari G; Quattrucci S; Minicucci L; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2019; 43(4S1):1-36. PubMed ID: 31370382
[TBL] [Abstract][Full Text] [Related]
7. Rate of Uptake of Ivacaftor Use after U.S. Food and Drug Administration Approval among Patients Enrolled in the U.S. Cystic Fibrosis Foundation Patient Registry.
Sawicki GS; Dasenbrook E; Fink AK; Schechter MS
Ann Am Thorac Soc; 2015 Aug; 12(8):1146-52. PubMed ID: 26073026
[TBL] [Abstract][Full Text] [Related]
8. [Italian Cystic Fibrosis Registry (ICFR). Report 2017-2018].
Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2021; 45(3 Suppl 1):1-37. PubMed ID: 34132083
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of malnutrition and obesity among cystic fibrosis patients.
Panagopoulou P; Fotoulaki M; Nikolaou A; Nousia-Arvanitakis S
Pediatr Int; 2014 Feb; 56(1):89-94. PubMed ID: 24003895
[TBL] [Abstract][Full Text] [Related]
10. Overweight and obesity in adults with cystic fibrosis: An Italian multicenter cohort study.
Gramegna A; Aliberti S; Contarini M; Savi D; Sotgiu G; Majo F; Saderi L; Lucidi V; Amati F; Pappalettera M; Palange P; Blasi F
J Cyst Fibros; 2022 Jan; 21(1):111-114. PubMed ID: 34053868
[TBL] [Abstract][Full Text] [Related]
11. Nutritional status and lung function in children with pancreatic-sufficient cystic fibrosis.
Madde A; Okoniewski W; Sanders DB; Ren CL; Weiner DJ; Forno E
J Cyst Fibros; 2022 Sep; 21(5):769-776. PubMed ID: 34972650
[TBL] [Abstract][Full Text] [Related]
12. Overweight and cystic fibrosis: An unexpected challenge.
Gabel ME; Fox CK; Grimes RA; Lowman JD; McDonald CM; Stallings VA; Michel SH
Pediatr Pulmonol; 2022 Feb; 57 Suppl 1():S40-S49. PubMed ID: 34738328
[TBL] [Abstract][Full Text] [Related]
13. Overweight, obesity and significant weight gain in adult patients with cystic fibrosis association with lung function and cardiometabolic risk factors.
Bonhoure A; Boudreau V; Litvin M; Colomba J; Bergeron C; Mailhot M; Tremblay F; Lavoie A; Rabasa-Lhoret R
Clin Nutr; 2020 Sep; 39(9):2910-2916. PubMed ID: 31982192
[TBL] [Abstract][Full Text] [Related]
14. [Italian Cystic Fibrosis Registry (ICFR). Report 2019-2020].
Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2022; 46(4 Suppl 2):1-38. PubMed ID: 36102313
[TBL] [Abstract][Full Text] [Related]
15. Excess weight in patients with cystic fibrosis: is it always beneficial?
González Jiménez D; Muñoz-Codoceo R; Garriga-García M; Molina-Arias M; Álvarez-Beltrán M; García-Romero R; Martínez-Costa C; Meavilla-Olivas SM; Peña-Quintana LR; Gallego Gutiérrez S; Marugán de Miguelsanz JM; Suárez Cortina L; Castejón Ponce EN; Leis Trabazo R; Martín Cruz F; Díaz Martín JJ; Bousoño García C
Nutr Hosp; 2017 Jun; 34(3):578-583. PubMed ID: 28627192
[TBL] [Abstract][Full Text] [Related]
16. Disease burden in people with cystic fibrosis heterozygous for F508del and a minimal function mutation.
Sawicki GS; Van Brunt K; Booth J; Bailey E; Millar SJ; Konstan MW; Flume PA
J Cyst Fibros; 2022 Jan; 21(1):96-103. PubMed ID: 34289939
[TBL] [Abstract][Full Text] [Related]
17. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
Southern KW; Patel S; Sinha IP; Nevitt SJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
[TBL] [Abstract][Full Text] [Related]
18. Registry-based study in people with cystic fibrosis and an
Higgins M; Farietta T; Campbell D; Liu M; Ostrenga J; Elbert A; Shih J; Volkova N
BMJ Open Respir Res; 2023 May; 10(1):. PubMed ID: 37230763
[TBL] [Abstract][Full Text] [Related]
19. [Italian Cystic Fibrosis Register - Report 2010].
Amato A; Ferrigno L; Salvatore M; Toccaceli V;
Epidemiol Prev; 2016; 40(2 Suppl 2):1-47. PubMed ID: 27291389
[TBL] [Abstract][Full Text] [Related]
20. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
De Boeck K; Weren M; Proesmans M; Kerem E
Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
